Cognota receives a go-ahead from US FDA for its BP monitoring device

By Ayushi Garg  | Date: August 22, 2022

Cognota receives a go-ahead from US FDA for its BP monitoring device

Leading healthcare technology company Cognota Healthcare has recently announced that its BP (blood pressure) monitoring device – COGNOHEALTH Blood Pressure Monitor, has received the United States Food and Drug Administration (US FDA) approval, enabling it to foray into the medical devices segment successfully.

This regulatory approval marks a significant breakthrough for the health-tech firm as it can now export its BP monitor devices to Europe, the US, and other countries abroad, while tapping the budding Indian market.

The COGNOHEALTH Blood Pressure Monitor is supported by cutting-edge technology developed and designed by the experts of Cognota’s R&D team.

Additionally, the recent development would enable Cognota to advance its current portfolio, which includes Teleconsultation Platform, Remote Patient Monitoring (RPM) and Smart ICU, among others.

Commenting on the latest development, Sanjeev Dahiwadkar, Founder & CEO of Cognota Healthcare, mentioned that the US FDA approval for ‘COGNOHEALTH Blood Pressure Monitor’ forms a groundbreaking move in the firm’s attempts to address the growing challenge of hypertension. The ailment is the most vulnerable health issue globally, given the people’s current lifestyles.

Sanjeev added that this approval for the in-house R&D device exonerates Cognota’s expertise in successfully deploying digital applications with innovative hardware components.

For the record, the US FDA approval is a thorough process in which all aspects of a healthcare device are investigated.

Furthermore, this advancement adds a feather to Cognota’s cap, demonstrating the firm’s technological depth, R&D bandwidth, and talent base.

Cognota has become a market leader in a short span of time, delivering several essential health tech solutions by integrating state-of-the-art software into hardware devices.

With some successful integrations, its healthtech solutions are being adopted increasingly by some well-recognized healthcare providers globally.

Notably, this US FDA approval will offer further impetus to the heath-tech major’s business.

Source credit –

About Author

Ayushi Garg

Ayushi Garg

Currently working as an associate content writer, Ayushi pens down insightful articles for several websites. She began her profession by taking classes in digital marketing to broaden her skills. Given her passion for writing, she took up several freelancing projects ...

Read More